BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27993881)

  • 21. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: a retrospective study.
    Kim DG; Lee J; Park Y; Kim MS; Jeong HJ; Kim SI; Kim YS; Kim BS; Huh KH
    BMC Nephrol; 2019 Dec; 20(1):456. PubMed ID: 31818254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased presence of anti-HLA antibodies early after allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood hematopoietic stem cell transplantation compared with bone marrow transplantation.
    Lapierre V; Aupérin A; Tayebi H; Chabod J; Saas P; Michalet M; François S; Garban F; Giraud C; Tramalloni D; Oubouzar N; Blaise D; Kuentz M; Robinet E; Tiberghien P;
    Blood; 2002 Aug; 100(4):1484-9. PubMed ID: 12149235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric evaluation of pregnancy-induced anti-HLA immunization and blood transfusion-induced reactivation.
    Rebibou JM; Chabod J; Alcalay D; Coussediere MC; Deteix P; Touchard G; Dupont I; Thévenin C; Chalopin JM; Tiberghien P
    Transplantation; 2002 Aug; 74(4):537-40. PubMed ID: 12352915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Flow Panel Reactive Assay (PRA) TM Specific Test with Complement Dependent Cytotoxicity (CDC) to Define the HLA Antibodies Specificity: A Preliminary Study.
    Kuda E; Al-Wahadneh A
    Saudi J Kidney Dis Transpl; 2001; 12(1):21-7. PubMed ID: 18209356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants.
    Kim Y; Yang CW; Moon IS; Kim M; Lim J; Park YJ; Han K; Oh EJ
    Ann Clin Lab Sci; 2010; 40(4):330-5. PubMed ID: 20947806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal transplantation in HLA sensitized patients: Traversing the immunological barrier.
    Pandey P; Setya D; Sinha V; Bhatt A; Devra A; Pande A; Kumar P; Ranjan S
    Ther Apher Dial; 2020 Oct; 24(5):578-590. PubMed ID: 31863544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful kidney transplantation across a positive complement-dependent cytotoxicity crossmatch by using C1q assay-directed, bortezomib-assisted desensitization: A case report.
    Lee J; Park BG; Jeong HS; Park YH; Kim S; Kim BS; Kim HJ; Huh KH; Jeong HJ; Kim YS
    Medicine (Baltimore); 2017 Sep; 96(39):e8145. PubMed ID: 28953652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anti-HLA antibodies in nephropathic patients].
    Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
    G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometry based detection of HLA alloantibody mediated classical complement activation.
    Wahrmann M; Exner M; Regele H; Derfler K; Körmöczi GF; Lhotta K; Zlabinger GJ; Böhmig GA
    J Immunol Methods; 2003 Apr; 275(1-2):149-60. PubMed ID: 12667679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA Desensitization Based on Results of the Luminex Technique in Kidney Transplant - A Single-center Experience.
    Bansal SB; Gade A; Sinha S; Mahapatra A; Jha P; Sethi SK
    Indian J Nephrol; 2021; 31(5):454-459. PubMed ID: 34880555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HLA and transfusion: new approaches with Luminex™ technology].
    Giannoli C; Nguyen TK; Dubois V
    Transfus Clin Biol; 2011 Apr; 18(2):218-23. PubMed ID: 21397543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-transplant donor specific antibody and its clinical significance in kidney transplantation.
    Thammanichanond D; Ingsathit A; Mongkolsuk T; Rattanasiri S; Kantachuvesiri S; Sakhonrat C; Leenanupan C; Worawichawongs S; Kitpoka P
    Asian Pac J Allergy Immunol; 2012 Mar; 30(1):48-54. PubMed ID: 22523907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
    Bućin D; Johansson S; Lindberg LO
    Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies.
    Amico P; Hönger G; Bielmann D; Lutz D; Garzoni D; Steiger J; Mihatsch MJ; Dragun D; Schaub S
    Transplantation; 2008 Jun; 85(11):1557-63. PubMed ID: 18551059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA and MICA allosensitization patterns among patients supported by ventricular assist devices.
    Askar M; Hsich E; Reville P; Nowacki AS; Baldwin W; Bakdash S; Daghstani J; Zhang A; Klingman L; Smedira N; Moazami N; Taylor DO; Starling RC; Gonzalez-Stawinski G
    J Heart Lung Transplant; 2013 Dec; 32(12):1241-8. PubMed ID: 24075503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometry PRA using lymphocyte pools from random donors.
    Won DI; Jung HD; Jung OJ; Huh S; Suh JS
    Cytometry B Clin Cytom; 2007 Jul; 72(4):256-64. PubMed ID: 17205570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of flow cytometric panel reactive antibody in renal transplant recipients - examination of 238 cases of renal transplantation.
    Ishida H; Tanabe K; Furusawa M; Ishizuka T; Hayashi T; Tokumoto T; Miyamoto N; Shirakawa H; Shimmura H; Shimizu T; Toma H
    Transpl Int; 2005 Feb; 18(2):163-8. PubMed ID: 15691268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.
    Fidler SJ; Irish AB; Lim W; Ferrari P; Witt CS; Christiansen FT
    Transpl Immunol; 2013 Jun; 28(4):148-53. PubMed ID: 23665534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical impact of the baseline donor-specific anti-human leukocyte antigen antibody measured by Luminex single antigen assay in living donor kidney transplant recipients after desensitization therapy.
    Chung BH; Choi BS; Oh EJ; Park CW; Kim JI; Moon IS; Kim YS; Yang CW
    Transpl Int; 2014 Jan; 27(1):49-59. PubMed ID: 24118413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.